Funda Suer Joins Orchid as Executive VP and Lab Medical Director, Bringing Expertise to Reproductive Genetic Testing for Healthier Futures

SAN FRANCISCO, Sept. 3, 2024 /PRNewswire/ — Orchid, a reproductive technology company offering the world’s only commercially available whole genome embryo screening, is thrilled to announce the appointment of Dr. Funda Suer as its new executive president and medical Director. Dr. Suer, a…